Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Mailing of 2024 Annual Report

10th Jun 2025 07:00

RNS Number : 0968M
MyCelx Technologies Corporation
10 June 2025
 

10 June 2025

 

MYCELX Technologies Corporation

 

("MYCELX" or the "Company") (AIM: MYX or MYXR)

 

Mailing of 2024 Annual Report

 

MYCELX Technologies Corporation ("MYCELX" or the "Company"), the clean water and clean air technology company transforming the environmental impact of industry, announces that, following the release on 12 May 2025 of the Company's Final Results for the year ended 31 December 2024, the 2024 Annual Report is today being mailed to shareholders.

 

Copies have been placed on the Company's website at www.mycelx.com. Copies will also be available free of charge from the Company's headquarters at 1650 International Court, Suite 100, Norcross, Georgia, USA 30093 for a period of at least one month.

 

Annual Meeting

 

The Company's 2025 Annual General Meeting will be held at 2:00 p.m. (BST) on Tuesday 23 September 2025 at the offices of Cavendish Capital Markets Limited, One Bartholomew Close, London, EC1A 7BL. The Notice of Annual Meeting will be mailed to Shareholders prior to the Annual Meeting.

 

 

For further information please contact:

 

MYCELX Technologies Corporation

Connie Mixon, CEO

Kim Slayton, CFO

 

 

 

Tel: +1 888 306 6843

Cavendish Capital Markets Limited (Nominated Adviser and Sole Broker)

Giles Balleny / Callum Davidson / Elysia Bough (Corporate Finance)

Jamie Anderson (Corporate Broking)

Jasper Berry / Michael Johnson (Sales)

 

 

Tel: +44 20 7220 0500

Celicourt Communications (Financial PR)

Mark Antelme

Jimmy Lea

Charlie Denley-Myerson

 

Tel: +44 20 7770 6424

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRUPURWQUPAPGB

Related Shares:

Mycelx Di
FTSE 100 Latest
Value8,735.60
Change16.85